BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8177462)

  • 1. [Adenocarcinoma of the endocervix. Clinical cases].
    Zarcone R; Tartaglia E; Cardone G; Voto RI
    Minerva Ginecol; 1994; 46(1-2):45-8. PubMed ID: 8177462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
    Schild R; Kutta T
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histological significance of atypical glandular cell on Pap smear.
    Behtash N; Nazari Z; Fakhrejahani F; Khafaf A; Azar EG
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):46-9. PubMed ID: 17261100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ThinPrep Pap test of endocervical adenocarcinoma with lymph node metastasis: report of a case in a 17-year-old woman.
    Wagner DG; Weisensel J; Mentrikoski MJ; Leo SD; Bonfiglio TA; Hoda RS
    Diagn Cytopathol; 2010 Sep; 38(9):633-8. PubMed ID: 19941367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of Pap smear cytology in the Western region of Saudi Arabia.
    Jamal A; Al-Maghrabi JA
    Saudi Med J; 2003 Nov; 24(11):1225-9. PubMed ID: 14647558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
    Bai H; Sung CJ; Steinhoff MM
    Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adenocarcinoma of the endocervix in material submitted to a central cytodiagnostic laboratory].
    Munck C
    Zentralbl Gynakol; 1984; 106(7):456-62. PubMed ID: 6730767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subdividing atypical glandular cells of undetermined significance according to the Australian modified Bethesda, system: analysis of outcomes.
    Roberts JM; Thurloe JK; Bowditch RC; Laverty CR
    Cancer; 2000 Apr; 90(2):87-95. PubMed ID: 10794157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal deviation endocervical adenocarcinoma--clinical, histologic and immunohistochemical study].
    Zhang JM
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):275-7. PubMed ID: 2625109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glandular cells in a cervical smear.
    Juric D; Ovanin-Rakić A; Audy-Jurković S; Kani D; Ilić-Forko J; Buković D
    Cytopathology; 2006 Oct; 17(5):299-300. PubMed ID: 16961660
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology.
    Zweizig S; Noller K; Reale F; Collis S; Resseguie L
    Gynecol Oncol; 1997 May; 65(2):314-8. PubMed ID: 9159344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.